Difference between revisions of "OncoMouse"

From Cyborg Anthropology
Jump to: navigation, search
Line 2: Line 2:
  
 
===Definition===
 
===Definition===
OncoMouse is both a noun and a trademark. It is a term used to describe a transgenic mouse carrying an activated human cancer gene, used in laboratory experiments.<ref>New Oxford American Dictionary</ref> OncoMouse also the first patented animal. Two patents were awarded to Harvard College that covered methods for providing a cell culture from a transgenic non-human animal.<ref>U.S. Patent 5,087,571; filed Mar 22, 1988, issued Feb 11, 1992, expired Feb 11, 2009) and testing methods using transgenic mice expressing an oncogene, U.S. Patent 5,925,803; filed Sep 19, 1991, issued Jul 20, 1999, expires July 20, 2016.</ref>
+
OncoMouse is both a noun and a trademark. OncoMouse describes a transgenic mouse carrying an activated human cancer gene, used in laboratory experiments.<ref>New Oxford American Dictionary</ref> Philip Leder and Timothy A Stewart<ref>European Patent Register entry for European patent no. 0169672, under "Inventor(s)". Consulted on February 22, 2008.</ref> of Harvard University designed the mouse to carry an activated oncogene, a specific gene that significantly increases the mouse’s susceptibility to cancer. This makes suitable for cancer research. The rights to the invention are owned by DuPont. "OncoMouse" is a registered trademark.<ref>Trademark: USPTO serial number 75797027</ref>
  
Philip Leder and Timothy A Stewart<ref>European Patent Register entry for European patent no. 0169672, under "Inventor(s)". Consulted on February 22, 2008.</ref> of Harvard University designed the mouse to carry an activated oncogene, a specific gene that significantly increases the mouse’s susceptibility to cancer. This makes suitable for cancer research. The rights to the invention are owned by DuPont. "OncoMouse" is a registered trademark.<ref>Trademark: USPTO serial number 75797027</ref>
+
OncoMouse also the first patented animal. Two patents were awarded to Harvard College that covered methods for providing a cell culture from a transgenic non-human animal.<ref>U.S. Patent 5,087,571; filed Mar 22, 1988, issued Feb 11, 1992, expired Feb 11, 2009) and testing methods using transgenic mice expressing an oncogene, U.S. Patent 5,925,803; filed Sep 19, 1991, issued Jul 20, 1999, expires July 20, 2016.</ref>
  
 
==References==
 
==References==

Revision as of 02:47, 6 November 2011

Definition

OncoMouse is both a noun and a trademark. OncoMouse describes a transgenic mouse carrying an activated human cancer gene, used in laboratory experiments.[1] Philip Leder and Timothy A Stewart[2] of Harvard University designed the mouse to carry an activated oncogene, a specific gene that significantly increases the mouse’s susceptibility to cancer. This makes suitable for cancer research. The rights to the invention are owned by DuPont. "OncoMouse" is a registered trademark.[3]

OncoMouse also the first patented animal. Two patents were awarded to Harvard College that covered methods for providing a cell culture from a transgenic non-human animal.[4]

References

  1. New Oxford American Dictionary
  2. European Patent Register entry for European patent no. 0169672, under "Inventor(s)". Consulted on February 22, 2008.
  3. Trademark: USPTO serial number 75797027
  4. U.S. Patent 5,087,571; filed Mar 22, 1988, issued Feb 11, 1992, expired Feb 11, 2009) and testing methods using transgenic mice expressing an oncogene, U.S. Patent 5,925,803; filed Sep 19, 1991, issued Jul 20, 1999, expires July 20, 2016.